Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross ‐sectional survey

ConclusionsWe found evidence of prevalent potential ‘off‐label’ use for psychotropic medication, which may be due to PBs. We also found evidence of potential diagnostic‐overshadowing, where symptoms of psychiatric co‐morbidity may have been attributed to PBs. Our findings provide renewed importance, across borders and health systems, for clinicians to consider a holistic approach to treating PBs, and attempting to best understand the precipitants and predisposing factors before psychotropic prescribing.

Source: Journal of Intellectual Disability Research - January 19, 2018 Category: Disability Authors: B. I. Perry, H. F. Kwok, J. Mendis, K. Purandare, A. Wijeratne, S. Manjubhashini, M. Dasari, F. Esan, I. Gunaratna, R. A. Naseem, S. Hoare, V. Chester, A. Roy, J. Devapriam, R. Alexander, S. E. Cooray Tags: Original Manuscript Source Type: research